Company intelligence / Profile preview

International Specialty Products

New Jersey, United States

Ownership: Private
Development stage: Other

Overview

International Specialty Products Inc. (ISP) was a privately held specialty chemicals company spun off from GAF Corporation via IPO in 1991. It focused on performance-enhancing chemicals for consumer markets, including personal care and pharmaceuticals applications. Ashland Inc. acquired ISP for $3.2 billion on August 23, 2011. Post-acquisition, ISP integrated into Ashland's operations and ceased independent existence.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on International Specialty Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Specialty Products.

Explore the full profile